In France, Global Bioenergies has reported a net loss of EUR 7.6 million for fiscal year 2014, which is a “significant but controlled increase compared to the 2013 figures.”
Operating expenses have risen by 61% compared to 2013. The various increases observed reflect the expanded workforce, which rose from 47 employees as at Dec. 31st, 2013 to 68 employees as at Dec. 31st, 2014. The strongest increase concerns the industrialization studies, which have led to the installation and startup of the industrial pilot in Pomacle-Bazancourt and will lead to the demo plant installation and startup in Leuna, Germany.
Global Bioenergies’ equity totaled [Eur]16.5m at the end of December compared to [Eur]23m at the end of 2013 and takes into account the net loss registered in 2014.
More on the story.
